Literature DB >> 16849675

Phase I antibody risks, trial safety examined.

Rabiya S Tuma.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16849675     DOI: 10.1093/jnci/djj315

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  1 in total

1.  TGN1412: From Discovery to Disaster.

Authors:  H Attarwala
Journal:  J Young Pharm       Date:  2010-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.